PTCommunity News August 2012

Benefits of Biologics Outweigh Risks in Rheumatoid Arthritis, Survey Finds
FDA Warns Against Use of Revatio (Sildenafil) in Children
Bayer Submits NDA for Regorafenib for Treatment of Gastrointestinal Stromal Tumors (GIST)
FDA Approves Linzess (Linaclotide) for IBS and Constipation
FDA Staff Question Efficacy of Tobramycin Inhaled Powder for Cystic Fibrosis
Xtandi (Enzalutamide) Gets Nod for Late-Stage Prostate Cancer
New Test May Allow Earlier Diagnosis of Liver Disease
NIH Study Links Protein to Increased Risk of Heart Failure in Older Adults
FDA Grants Priority Review of Zytiga (Abiraterone Acetate) for Metastatic Prostate Cancer
COPD Drug Meets Primary Endpoint in Phase III Trial
FDA Okays Biosimilar Tbo-filgrastim for Chemotherapy-Induced Neutropenia
Aspirin May Prolong Survival in Men With Prostate Cancer
New Antibacterial Coating for Sutures Could Reduce Infection After Surgery
Extended-Release Oxycodone Enters Phase III Trial for Lower Back Pain
Lilly Stops Phase III Development of Schizophrenia Drug
FDA Approves Nucynta ER (Tapentadol) for Neuropathic Pain
Smoking After Stroke Increases Death Risk by Three-Fold
ICU Errors May Cause as Many Deaths as Breast Cancer
FDA Approves Four-Drug Tablet for Treatment of HIV Infection
Phase II Results Reported for Pain Drug in Postherpetic Neuralgia
Virus May Cause Diabetes in the Elderly
Study Describes Noninvasive Method for Diagnosing Epilepsy
Biotechnology Firm Obtains Funding for New HBV/HIV Vaccines
A New Target for Treatment of Chronic Pain
FDA Questions Benefit of Adalimumab (Humira) in Bowel Disease
Alzheimer’s Drug Fails to Meet Primary Endpoints in Phase III Trials
GSK Completes Phase III Trials for Combination Lung Drug
New ‘Smart’ Catheter Fights Catheter-Related Infections
Researchers Foresee ‘Antivirulence Drugs’ for Antibiotic-Resistant Bacterial Infections
Sirukumab Enters Late-Stage Program for Rheumatoid Arthritis
FDA Okay’s Testing of Surgical Weight-Loss Device in Diabetic Patients
Microbiologists Find New Approach to Treating Viral Illnesses
NIH Launches Study of Methotrexate for Prevention of Heart Attacks, Strokes, and Cardiovascular Deaths
First Evidence in Humans on How Alcohol May Boost Cancer Risk
CDC Reports Sharp Spike in West Nile Cases, Deaths
Study Reveals New Link to Asthma
Researchers Identify Markers That Predict Progression of Oral Lesions to Cancer
New Technology May Transform Blood Processing
FDA Delays Opinion on Tofacitinib for Rheumatoid Arthritis
A New Therapeutic Target in Alzheimer’s Disease
Novartis Challenges India’s Top Court in Patent Case
Researchers Aim to Develop Blood Test for Lung Cancer
Common Antifungal Agent May Decrease Tumor Growth
Scientists Identify Mechanisms in Kidney Disease That Trigger Heart Attacks and Strokes
This Season’s Swine Flu Appears Mild
No Evidence That Misoprostol (Cytotec) Prevents Life-Threatening Bleeding in Women During Labor
A Photographic Cholesterol Test
Company Launches Comprehensive Testing for "Bath Salts" and Designer Stimulant Drugs
New Technology Combats Drug Counterfeiting
Pilot Program Evaluates New Healthcare App
Health Panel Likely to Make HIV Tests Routine
Brain Parasite Linked to Suicide Attempts
Eye Drug Shows Promise in Elderly Patients
Research Firm Predicts Uptake of Only Three New Breast Cancer Drugs Through 2021
NIH Report Details Health, Economic Status of Older Americans
Novel “Coagulometer” Expected on the Market Next Year
Scientists Show How Treatment-Resistant Bacterial Infections May Form
B Cell Survival Holds Key to Graft-Versus-Host Disease
CDC Issues New Recommendations on Hepatitis C Screening
New Drug Increases Survival in Prostate Cancer Patients
Some Children Risk Death With Codeine, FDA Warns
Denosumab More Effective Than Zoledronic Acid for Breast Cancer Patients With Bone Metastases (Aug. 14)
Blood Type May Influence Heart Disease Risk (Aug. 14)
New Treatment Target Identified for Melanoma Skin Cancer (Aug. 15)
Report Challenges Common Treatment for Mild Hypertension (Aug. 15)
Scientists Discover Mechanism to Block Heroin and Morphine Addiction (Aug. 15)
New Discovery Points to Vaccine for Heart Disease
Analysis Finds That 12 States Have Adult Obesity Rates Above 30%
Diabetes Drugs Increase Risk of Bladder Cancer
Older Women With Early-Stage Breast Cancer Benefit From Radiation After Lumpectomy
FDA Approves Vaccine Formulation for 2012–2013 Flu Season
“Harmless” Condition Alters Brain Function in Elderly
New Bacteria-Resistant Materials May Reduce Hospital Infections
FDA Approves Lucentis (Ranibizumab Injection) for Diabetic Macular Edema
Rapid Diagnostic Tests May Miss New Swine Flu, CDC Warns
Ampyra (Dalfampridine) Fails Main Goal of Post-Marketing Study in Patients With Multiple Sclerosis
CDC Updates Guidelines on Sexually Transmitted Disease
Smoking Increases Risk of Cancers of the Blood, Immune System, and Bone Marrow in Women
New Standards to Improve Diagnosis of Sjögren’s Syndrome
Avastin (Bevacizumab) Slows Brain Cancer Tumor Growth in Phase III Trial
FDA Approves Marqibo (Vincristine Sulfate Liposome Injection) for Rare Leukemia
New Approach for Detecting Hard-to-Diagnose Prostate Cancer
Generic Tuberculosis Vaccine May Help Patients With Type 1 Diabetes
Phase III Trial Planned for Oral Laquinimod in Relapsing-Remitting Multiple Sclerosis
Depression Linked to Increased Risk of Peripheral Artery Disease
Amgen Terminates Study of Ganitumab in Metastatic Pancreatic Cancer
Cancer Breakthrough May Lead to More Effective Treatments
New Therapeutic Target for Diabetes and Wolfram Syndrome
Pfizer, J&J Scrap Alzheimer’s Studies After Drug Fails
Results Announced From Phase III Study of Forteo (Teriparatide) in Postmenopausal Women With Back Pain Caused by Vertebral Fractures
Oral Corticosteroids Ineffective for Rhinosinusitis
New Class of Cancer Drugs Reduces Cellular Damage From Chemotherapy
Company Discovers New Antibiotic Compound
Humira (Adalimumab) Maintains Remission in Children With Crohn’s Disease
Blood Biomarker Identifies Early Lou Gehrig's Disease
Pasireotide Tested in Patients With Neuroendocrine Tumors
Researchers Discover New Mechanism Behind Resistance to Cancer Treatment
FDA Sets Action Date for Enzalutamide for Treatment of Prostate Cancer
Primary Endpoint Met in Phase IV Study of Toviaz (Fesoterodine Fumarate) for Overactive Bladder
CDC Reports Improvement in Heart Risk Factors for Americans
“Toxic” Estrogen By-Product Linked With Pulmonary Arterial Hypertension
FDA Approves Zaltrap (Ziv-Aflibercept) for Metastatic Colorectal Cancer
GSK Submits NDAs for New Melanoma Drugs
Study Finds Generic Medications Saved $1 Trillion Over Past Decade
Breast Cancer Charity Under Fire for Overstating Benefits of Screening
New Obesity Measure Predicts Early Death Better Than BMI
Revised Guidelines Issued for Use of Painkillers in Chronic Non-Cancer Pain
Drug Combination Slows Breast Cancer Relapse
BMS Halts Study of Hepatitis C Drug
Scientists Unlock Genetic Secrets of Peripheral T-Cell Lymphomas
FDA Questions Treatment for Immune Deficiency Disorders

You are here

PTCommunity News August 2012